PCVAX | VISVX | PCVAX / VISVX | |
Total Expense Ratio | 1.17 | 0.19 | 616% |
Annual Report Gross Expense Ratio | 1.23 | 0.19 | 647% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | -2.673 | 2.868 | -93% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 261M | 55.6B | 0% |
Annual Yield % from dividends | 1.36 | 1.99 | 68% |
Returns for 1 year | -6.18 | 5.54 | -112% |
Returns for 3 years | -9.18 | 30.99 | -30% |
Returns for 5 years | 10.67 | 88.78 | 12% |
Returns for 10 years | -48.78 | 102.36 | -48% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CSSYX | 23.48 | 0.19 | +0.82% |
Columbia Select Small Cap Value Inst3 | |||
HIBCX | 54.87 | 0.22 | +0.40% |
Hartford Capital Appreciation HLS IB | |||
BVEIX | 21.95 | 0.08 | +0.37% |
Becker Value Equity Institutional | |||
PAGLX | 46.04 | 0.09 | +0.20% |
T. Rowe Price Global Growth Stock Adv | |||
CNWAX | 89.13 | -0.42 | -0.47% |
American Funds New World 529A |